Acetaminophen remains the drug of choice for occasional use in patients with kidney disease because of bleeding complications that may occur when these patients use aspirin.
The antibiotic trimethoprim-sulfamethoxazole and the H2-blocker cimetidine are 2 commonly used drugs that decrease the secretion of creatinine. This can result in a self-limited and reversible increase in the serum creatinine level of as much as 0.4 to 0.5 mg/dL (depending on baseline serum creatinine level).
Tramadol immediate-release tablet: If you have severe kidney problems, your doctor will likely prescribe you 50–100 mg every 12 hours. The maximum dosage is 200 mg per day. Tramadol extended-release tablet: If you have severe kidney problems, you should not use these forms of tramadol.
Antihistamine tablets, nasal sprays and eyedrops, including well-known brands such as Piriton (chlorpheniramine) and Clarityn (loratadine), are safe to take to relieve allergy symptoms. Preparations containing sodium cromoglycate, such as Opticrom Eye Drops, are also safe.
A GFR of 60 or over is considered normal, a GFR less than 60 may indicate kidney disease. A level of 15 or less is defined medically as kidney failure.
What are the signs of end-of-life kidney failure?
- Water retention/swelling of legs and feet.
- Loss of appetite, nausea, and vomiting.
- Confusion.
- Shortness of breath.
- Insomnia and sleep issues.
- Itchiness, cramps, and muscle twitches.
- Passing very little or no urine.
- Drowsiness and fatigue.
Which herbal supplements should I avoid if I have kidney disease?
| Astragalus | Barberry | Cat's Claw |
|---|
| Apium Graveolens | Creatine | Goldenrod |
| Horsetail | Huperzinea | Java Tea Leaf |
| Licorice Root | Nettle, Stinging Nettle | Oregon Grape Root |
| Parsley Root | Pennyroyal | Ruta Graveolens |
The herbs listed by the National Kidney Foundation as having negative side effects on the renal system included alfalfa, aloe, bayberry, broom, buckthorn, capsicum, cascara, dandelion, ginger, ginseng, horsetail, licorice, ma huang, nettle, noni, pokeroot, rhubarb, senna, wormwood and yohimbe.
An alternative anticoagulant such as unfractionated heparin may be preferred, especially for individuals with CrCL <30 mL/min, renal failure, or receiving dialysis. Examples of alternatives include: Unfractionated heparin. An LMW heparin with lower renal clearance.
For outpatients with moderate renal impairment (creatinine clearance 30-50 mL/minute), the NOACs appear to be at least as safe as warfarin. Of the NOACs, apixaban is the least dependent on renal clearance and so it can be used in advanced CKD.
However, blood thinners can increase risk of bleeding, which is dangerous for individuals at high risk—including those with kidney disease.
Recently, it was found that warfarin causes renal damage in patients with chronic kidney disease and is also associated with progression of renal disease. Warfarin causing acute kidney injury in patients with normal renal function is a rare manifestation.
Chronic renal impairment is considered a relative contraindication to use of tranexamic acid due to reports of ureteric clots and acute renal failure from cortical necrosis. We conclude that tranexamic acid can be used safely in some patients with CKD and polycystic kidney disease to treat severe hematuria.
LMWHs have the potential to accumulate in renal failure as they depend on renal elimination and can lead to bleeding complications in patients with CKD 4–5. 27,28 Certoparin, nadroparin, reviparin, danaparoid, and fondaparinux are not recommended or contraindicated in patients with a GFR <30 mL/min.
Digoxin has a small therapeutic-to-toxic margin in patients with CHF (2), particularly in those patients who often have renal dysfunction, and it is therefore logical that, in recent years, numerous physicians have stopped using digoxin for the treatment of patients with CHF on hemodialysis.
In addition to loss of blood, clotting within the capillary fibers of the dialyzer results in reduced solute clearances and a shortened dialyzer lifespan. Thus, some form of anticoagulation (eg, unfractionated heparin [UFH]) is typically administered at the time of dialysis to prevent clotting in the blood circuit.
For people with kidney disease: If you have severe kidney disease or a history of kidney disease, taking heparin can increase your risk of bleeding. Talk to your doctor before using heparin.
